November 17, 2020




U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549

Attention: Margaret Schwartz




Aravive, Inc.



Registration Statement on Form S-3



File No. 333-248612


Ladies and Gentlemen:


Aravive, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-248612), be accelerated by the U.S. Securities and Exchange Commission to Friday, November 20, 2020 at 9:00 a.m., Eastern Time, or as soon as reasonably practicable thereafter.


The Company hereby authorizes its legal counsel, Leslie Marlow and/or Patrick Egan of Gracin & Marlow, LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 496-2223 or (212) 907-6457 or Mr. Egan at (914) 557-5574 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.




Very truly yours,





Aravive, Inc.






/s/ Vinay Shah



Name: Vinay Shah



Title: Chief Financial Officer






 cc:    Leslie Marlow, Esq.

         Patrick J. Egan, Esq.